Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/153437| Title: | Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD |
| Author: | Laidlaw, Tanya M. Mullol i Miret, Joaquim Fan, Chunpeng Zhang, Donghui Amin, Nikhil Khan, Asif Chao, Jingdong Mannent, Leda P. |
| Keywords: | Sinusitis Asma Sinusitis Asthma |
| Issue Date: | 4-Apr-2019 |
| Publisher: | Elsevier |
| Abstract: | In the difficult-to-treat subgroup of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and comorbid aspirin-exacerbated respiratory disease, dupilumab significantly improved CRSwNP disease outcomes, along with asthma control and lung function. This is preliminary evidence of the effect of dupilumab in patients with CRSwNP and comorbid aspirin- exacerbated respiratory disease. |
| Note: | Versió postprint del document publicat a: https://doi.org/10.1016/j.jaip.2019.03.044 |
| It is part of: | The Journal of Allergy and Clinical Immunology: In Practice, 2019, vol. 7, num. 7, p. 2462-2465.e1 |
| URI: | https://hdl.handle.net/2445/153437 |
| Related resource: | https://doi.org/10.1016/j.jaip.2019.03.044 |
| Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 12474_4793271_Amin.pdf | 800.23 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
